Genesis Biosystems

Genesis Biosystems is an innovator in the field of aesthetic medical devices and treatments. We specialize in skin rejuvenation systems, which include our patented DermaFrac C device. DermaFrac C is the next generation in micro-needing, offering simultaneous Microneedle + Infusion, the procedure infuses potent topical solutions that target different skin anomalies with zero downtime, no pain and no topical anesthetic required. Overall, providing a safer, more predictable, and effective treatment than traditional micro-needling. Genesis Biosystems recent launch, Dermacel, a Professional and Patient Peel System, provides a simple, safe, effective, and predictable peel treatment program for all skin types. Available in...

Aesthetic and biomedical device manufacturer,dermafrac™ micro-channeling system,infusion peel™ microdermabrasion + infusion,gf-r™ growth factor rejuvenating complex,derma genesis® microdermabrasion,derma peel® crystal-free microdermabrasion,lipivage® autologous fat transfer system,tissu-trans® filtron® autologous fat transfer system,and skin rejuvenation systems

Genesis biosystems operates in the Medical equipment manufacturing industry.

Genesis biosystems's revenue is 11m - 100m

Genesis biosystems has 11 - 50 employees.